Thirteen of the 20 cities in which a clinical trial was conducted for an artificial blood substitute had minority populations greater than that of the nation as a whole.
Thirteen of the 20 cities in which a clinical trial was conducted for an artificial blood substitute had minority populations greater than that of the nation as a whole.